Ben Greene

Q: What is Ben Greene email address?

Email Ben Greene at greenezoo@verizon.net. This email is the most updated Ben Greene email found in 2026.

Q: How to contact Ben Greene?

To contact Ben Greene send an email to greenezoo@verizon.net. If you want to call Ben Greene try calling on +15089489491.

Biotech/Pharma Consultant at Guidepoint | Hopkinton, Massachusetts, United States

About Ben Greene

Ben Greene is a seasoned Principal Scientist 3 at Charles River Laboratories, where he plays a pivotal role in advancing pharmacokinetic discovery within the biotechnology and pharmaceutical sectors. With over 25 years of experience, Ben has cultivated a deep expertise in drug discovery and development, focusing on the intricate interplay between biologics and their pharmacokinetic profiles. His current responsibilities as a Study Director involve leading multidisciplinary teams to design and execute comprehensive studies that assess drug behavior in preclinical models.

Ben's proficiency in WinNonlin for pharmacokinetic analysis, coupled with his adeptness in protocol development, allows him to streamline complex study designs while ensuring regulatory compliance and scientific rigor. He is particularly skilled in utilizing animal models to simulate human physiology, providing critical insights that inform drug safety and efficacy. His commitment to excellence is evident in his technical writing, where he translates complex data into actionable insights for stakeholders, thereby enhancing program support and decision-making processes.

At Charles River, Ben has spearheaded key projects that have not only advanced the understanding of drug mechanisms but have also contributed to the successful transition of several candidates into clinical trials. His expertise in safety pharmacology further underscores his holistic approach to drug development, ensuring that potential risks are identified and mitigated early in the process. As a thought leader in the industry, Ben Greene continues to drive innovation and foster collaboration, making significant contributions to the future of therapeutic advancements.

Ben Greene Work